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Accepted 18 May 2012AbstractObjective: We describe the serial computed tomography (CT) findings of extensive hepatic infarction and successful plasma exchange therapy in
a severe preeclamptic woman with postpartum HELLP syndrome.
Case Report: A 38 year-old woman presented with elevated blood pressure of 140e180/90e120 mmHg and 3þ proteinuria at 28 weeks of
gestation. Two days after admission, the patient suddenly complained of severe epigastric pain and headache. Her blood pressure rose sharply to
195/120 mmHg. A 980 g female was delivered by emergency cesarean section. Following delivery, the patient’s clinical condition and laboratory
values deteriorated, with progressive liver insufficiency (peak AST level ¼ 4246 IU/L, ALT ¼ 3685 IU/L, LDH ¼ 6237 IU/L,
platelets ¼ 72,000/mm3). Two consecutive plasma exchanges (PEX) were undertaken on the 3rd and 4th postpartum day. A contrast-enhanced CT
of the abdomen performed 8 days postpartum showed geographically wedge-shaped areas of low attenuation, with a mottled appearance in the
right hepatic lobe. Shortly thereafter, the patient recovered and all laboratory parameters gradually normalized 3 weeks after delivery. Follow-up
CT-scan of the liver 2 months postpartum showed no evidence of infarction, with complete recovery.
Conclusion: We recommend that severely ill patients with HELLP syndrome having epigastric pain should undergo CT imaging of the liver. A
trial of postpartum PEX therapy should be considered for treatment of the HELLP syndrome complicated with hepatic infarction, which is
recalcitrant to conventional medical management, and fails to abate within 72e96 hours of delivery.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Patients with HELLP syndrome may have various symp-
toms and signs, although Sibai et al noted that 90% of patients
with HELLP syndrome complain of epigastric or right upper* Corresponding author. Department of Obstetrics and Gynecology,
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Taichung, Taiwan.
E-mail address: mmchou@vghtc.gov.tw (M.-M. Chou).
1028-4559/$ - see front matter Copyright  2012, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2012.07.018quadrant pain [1e5]. These symptoms are thought to result
from obstruction of blood flow in the hepatic sinusoids,
because of large hyaline deposits of fibrin-like materials
associated with periportal or focal parenchymal necrosis [2,4].
In certain rare cases, the hepatocellular necrosis and hemor-
rhage may be severe enough to result in liver infarction. These
characteristic findings have been confirmed by histopatho-
logical examination [4].
The therapeutic application of plasma exchange (PEX)
therapy with fresh frozen plasma (FFP) for the arrest ofcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Contrast-enhanced CT axial image through liver and spleen shows
geographically inhomogeneous wedge-shaped areas of low attenuation with
mottled appearance and enhanced vessels coursing through these hypodense
areas, mainly in the right hepatic lobe.
Fig. 2. An enhanced CT scan of the liver 2 months postpartum shows no
evidence of hepatic infarction with complete recovery.
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reported in literatures [6e9]. In this case report, we describe
the serial computed tomography (CT) findings of extensive
hepatic infarction and successful experimental high dose
corticosteroid therapy and PEX therapy in a severely
preeclamptic woman with postpartum HELLP syndrome.
Case report
A 38-year-old woman, gravida 3, para 2, presented at 28
weeks’ gestation with elevated blood pressure of 140e180/
90e120 mmHg and 3þ proteinuria. The patient’s past
obstetric history was significant for one intrauterine fetal death
at 24 weeks of gestation, with unknown causes. LFTs and
a CBC examination were within the normal range on admis-
sion. Betamethasone 12 mg IM q 24 hours for two doses was
given for enhancing fetal lung maturation. Two days after
admission, the patient suddenly complained of severe
epigastric pain and headache. Her blood pressure rose sharply
to 195/119 mmHg. An emergency cesarean section was per-
formed. A 980 g female was born with Apgar scores 3, 6, and
7 at 1, 5, and 10 minutes, respectively.
The maternal platelet count fell from 183,000 to 125,000/
mm3; the ALT level increased from 34 IU/L on admission to
542 IU/L, and LDH level increased from 224 IU/L to 1125 IU/
L immediately after cesarean section. The peak total bilirubin
level was 0.9 mg/dL. Antiphospholipid syndrome survey with
laboratory tests of antiphospholipid antibody (Ab), anti-beta2-
glycoprotein Ab, anticardiolipin Abs and lupus anticoagulant
were assessed and were found to be negative.
Following delivery, the patient’s clinical condition and
laboratory values deteriorated, with progressive liver insuffi-
ciency (peak AST level ¼ 4246 IU/L, ALT ¼ 3685 IU/L,
LDH ¼ 6237 IU/L) 2 days postpartum. A CBC study showed
a sharp increase in WBC level to 29,200/mm3, and a platelet
count nadir of 72,000/mm3. Bedside liver ultrasonography
revealed a heterogeneous hypoechoic area 10 cm in diam-
eter, mainly in the right lobe.
Because of the severity of disease, the patient received
experimental postpartum high dose corticosteroid therapy with
dexamethasone 10 mg IV q 12 hours for two doses, followed
by 5 mg q 12 hours for two doses. Additionally, PEX therapy
with 26 units of FFP as the only replacement fluid, using an
Asahi plasma separator OP-05W (Asahi Kasei Kuraray
Medical Co., Ltd., Tokyo, Japan) was undertaken on the 3rd
postpartum day. A second PEX procedure with 24 units of FFP
was performed empirically 24 hours later, based on the
patient’s composite clinical and laboratory assessment. The
patient was monitored closely for signs and symptoms of
adverse reactions or complications during and immediately
after PEX.
Contrast-enhanced CT of the abdomen performed 8 days
postpartum showed geographically inhomogeneous wedge-
shaped areas of low attenuation with a mottled appearance
and enhanced vessels coursing through these lesions mainly in
the right hepatic lobe (Fig. 1). These hypodense lesions were
compatible with hepatic infarction.Shortly after PEX adjunctive therapy to traditional
supportive care, the severely ill patient recovered, without
maternal complications, and all laboratory parameters gradu-
ally normalized 3 weeks after delivery. An enhanced follow-up
CT-scan of the liver 2 months postpartum showed no evidence
of hepatic infarction, with complete recovery (Fig. 2).
Discussion
Extensive hepatic infarction is a very severe disease which
accounts for preeclampsia-eclampsia related death in 11% of
patients [4], but fortunately is a very rare extension of the
HELLP syndrome, because of the liver’s dual blood supply.
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as unintentional ligation of the hepatic artery during surgery,
decreased portal venous flow, emboli, thrombosis and anti-
phospholipid syndrome (APS) [10]. A toxemic vasculopathy
related to severe vasospasm in the hepatic arterial circulation,
may be responsible for a central role in the pathophysiologic
features of hepatic infarction [4]. Increasing evidence also
indicates that HELLP syndrome is a placenta-instigated, liver-
targeted, acute inflammatory condition and disordered
immunologic process [5]. Systemic CD95 ligand is a placenta-
derived humoral factor that is involved in the pathogenesis of
HELLP syndrome. CD95 (APO-1, Fas; TNFRSF6)-mediated
apoptosis of hepatocytes is a major pathogenic mechanism
for liver disease in general. Apoptosis in liver tissue and
cytotoxic activity for primary human hepatocytes has been
reported in serum from patients with HELLP syndrome.
Blocking of CD95 signaling reduces the hepatocytotoxic
activity of HELLP syndrome [5].
Pregnancy-related liver diseases are complex in presentation
and often confusing to clinicians, leading to misdiagnoses and
unwarranted or delayed therapies. Accurate diagnosis may not
be possible on the basis of clinical presentations and laboratory
evaluation alone. Ultrasonography can be used as a screening
tool. However, CT of the liver appears to be the imaging
modality of choice in the differential diagnosis of hepatic
dysfunction in late pregnancy and postpartum, because it ismore
available, faster and safer for potentially unstable patients. The
characteristic imaging findings are inhomogeneous areas of low
attenuation, either wedge-shaped lesions peripherally or
geographically, or larger lesions, with enhanced vessels,
coursing through these hypodense areas [11].
Delivery of the placenta with decidual tissues is the
definitive therapy for gravid women with severe preeclampsia-
eclampsia, with or without HELLP syndrome. However,
a very small subgroup of gravid women with severe HELLP
syndrome, fail to undergo preeclamptic disease arrest and
reversal after expeditious delivery and conventional obstetric
medical management within 72 to 96 hours of delivery. In
these rare patients with unremitting disease, it is still a chal-
lenging problem that is associated with significant maternal
morbidity and mortality and an alternative therapy is needed.
PEX with FFP works via either the removal of insulting
agents such as placenta-derived humoral factors, immune
antibodies, nonspecific factors and cellular debris, or the
supplementation of deficient plasma factors, which reduces
platelet aggregation and permits endothelial recovery [6e9].
Optimal guidelines for FFP volume and duration of therapy
are difficult to establish. We recommend two consecutive daily
PEXs and then observation for 24 to 48 hours before a deci-
sion to continue daily or alternate day therapy, if laboratory
and clinical information does not suggest a trend toward
resolution of hepatic infarction.Although a recent review published in The Cochrane Library
on the subject concluded that there is insufficient evidence to
determine whether adjunctive corticosteroid use in women with
HELLP syndrome decreases major morbidity [12], we still
recommend that timely experimental postpartum high dose
corticosteroid therapy [5], combined with PEX [6e9], may be
life-saving in properly selected patients. We caution that ther-
apeutic time window is narrow for persistently severe
preeclampsia-eclampsia with postpartum HELLP syndrome.
In conclusion, preeclamptic patients with HELLP syndrome,
with complaints of severe epigastric or right upper quadrant
pain, should undergo imaging of the liver. Therapeutic modality
of PEX with FFP can be employed effectively for the pregnant
patient with severely atypical HELLP syndrome complicated
with advanced hepatic infarction, which progressively worsens
during labor or the early puerperium.References
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